Sapphiros grants Roche access to 1 billion lateral flow tests annually

Sapphiros announced a strategic supply and manufacturing option agreement with Roche, granting Roche exclusive rights to at least 1 billion lateral flow tests annually from Sapphiros' UK manufacturing facility, plus access to future molecular point-of-care tests.

“Agreement secures rapid, global access to tests for future pandemics and health emergencies”sapphiros.com

• 1 source
• sapphiros.comSapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests. · SapphirosNov 19, 2025

Summarized from public sources; check the original articles before acting on it.